Relationship Between Simulated Gadolinium-Based Contrast Agent Injection Profile and Achievable Resolution Metrics in Contrast-Enhanced Magnetic Resonance Angiography

被引:2
|
作者
Clark, Toshimasa J. [1 ]
Wilson, Gregory J. [2 ]
Maki, Jeffrey H. [1 ]
机构
[1] Univ Colorado, Dept Radiol, Abdominal Imaging Sect, Aurora, CO USA
[2] Bayer Healthcare, Bayer Radiol, Whippany, NJ USA
关键词
magnetic resonance angiography; contrast-enhanced magnetic resonance angiography; simulation; GADOBENATE DIMEGLUMINE; LIMITS;
D O I
10.1002/jmri.27966
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background Contrast bolus variation during contrast-enhanced magnetic resonance angiography (CE-MRA) acquisition may lead to vessel blurring. Purpose To combine knowledge of how contrast signal intensity (SI) evolves for different injection strategies with anatomically familiar parametric computer models to measure and visually assess the effects of a wide range of variables on modeled CE-MRA, and in doing so develop contrast rate injection guidelines. Study Type Computer modeling. Phantom Digital three-dimensional phantom consisting of orthogonal "aorta," 7 mm diameter "renal arteries" (with 57% and 86% diameter stenoses), and 7 mm diameter "superior mesenteric artery" (with 57% diameter stenosis). Field Strength/Sequence One millimeter in-plane resolution arterial CE-MRA imaging at 3 T. Assessment "Background" (time invariant) and "vascular" (time varying) components of the phantom were each Fourier transformed into the spatial frequency domain, the latter modulated by the SI evolution of a contrast bolus of varying "plateau" lengths and "tail" heights. Data are presented as surface plots of stenosis measurement error and blurring vs. a reference-standard injection. Statistical Tests Descriptive. Results Shorter plateau lengths and lower tail heights resulted in increased measured stenosis error and blurring vs. the reference standard. Under a 44-second acquisition, full width half maximum stenosis error of the 86% stenosis with 25% plateau length and 25% tail height is 24% as compared to that from the reference standard. As plateau length and tail height approach 100%, stenosis error and blurring approach a floor defined by the MR acquisition's limitations. Data Conclusion We propose that to achieve minimal degradation with CE-MRA, one can create a contrast bolus with either 60% plateau and 50% tail height or 80% plateau with any tail. These considerations may well prove to be of practical importance, possibly via manipulating the tail by means of multiphasic contrast injections. Level of Evidence 3 Technical Efficacy Stage 1
引用
收藏
页码:1797 / 1807
页数:11
相关论文
共 50 条
  • [1] Editorial for "Relationship Between Simulated Gadolinium-Based Contrast Agent Injection Profile and Achievable Resolution Metrics in Contrast-Enhanced Magnetic Resonance Angiography"
    Roditi, Giles
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2022, 55 (06) : 1808 - 1809
  • [2] Contrast-Enhanced Magnetic Resonance Angiography
    Vasile, Julie V.
    Newman, Tiffany M.
    Prince, Martin R.
    Rusch, David G.
    Greenspun, David T.
    Allen, Robert J.
    Levine, Joshua L.
    CLINICS IN PLASTIC SURGERY, 2011, 38 (02) : 263 - +
  • [3] Contrast-Enhanced Magnetic Resonance Angiography
    Chandra, Tushar
    Pukenas, Bryan
    Mohan, Suyash
    Melhem, Elias
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2012, 20 (04) : 687 - +
  • [4] Contrast-enhanced magnetic resonance angiography
    Roditi, G
    BRITISH JOURNAL OF SURGERY, 2002, 89 (07) : 817 - 820
  • [5] A gadolinium-based magnetic resonance imaging contrast agent for nucleotides sensing
    Kong, Jichuan
    Liu, Zhengkang
    Cai, Dongxu
    Fan, Yunchang
    Zhao, Peiran
    Liu, Xing
    Pu, Peng
    Song, Lufei
    He, Cheng
    SENSORS AND ACTUATORS B-CHEMICAL, 2018, 256 : 913 - 920
  • [6] Extended blood circulation of a macromolecular gadolinium-based T1 contrast agent for vascular dynamic contrast-enhanced magnetic resonance imaging
    Jenjob, Ratchapol
    Kun, Na
    Ghee, Jung Yeon
    Lee, Don Haeng
    Yang, Su-Geun
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2016, 12 (02) : 504 - 504
  • [7] Contrast-enhanced MR Angiography without Gadolinium-based Contrast Material: Clinical Applications Using Ferumoxytol
    Jalili, Mohammad H.
    Yu, Tiffany
    Hassani, Cameron
    Prosper, Ashley E.
    Finn, J. Paul
    Bedayat, Arash
    RADIOLOGY-CARDIOTHORACIC IMAGING, 2022, 4 (04):
  • [8] Toxicity associated with gadolinium-based contrast-enhanced examinations
    Lattanzio, Silvia Maria
    AIMS BIOPHYSICS, 2021, 8 (02): : 198 - 220
  • [9] Transport of contrast agents in contrast-enhanced magnetic resonance angiography
    Jou, LD
    Rapp, J
    Saloner, D
    MAGNETIC RESONANCE IMAGING, 2004, 22 (04) : 495 - 504
  • [10] Evaluation of a novel gadolinium-based contrast agent for intraoperative magnetic resonance imaging
    Madsen, Steen J.
    Wu, Genevieve N.
    Chow, Rayland
    Kim, Sung-Yop
    Hirschberg, Henry
    PHOTONIC THERAPEUTICS AND DIAGNOSTICS IV, 2008, 6842